Hero_Icon_LandingPage.png 

Today there's more opportunity for doctors
to counsel better, forecast better, plan better
 
PREDICT BETTER
WITH TUMOR MUTATIONAL BURDEN
 
Logo_Foundation_One_1.png

STAY INFORMED!
Treating cancer is complicated. New research, more medicines, evolving patient needs.
Stay informed with Foundation Medicine's mailing list:

Immunotherapy_Icon_LandingPage.png
 
ABOUT IMMUNOTHERAPY
 
TMB can predict the efficacy of immunotherapy, a type of
treatment that harnesses the power of the body's own immune
system to attack cancer cells
 
         WATCH THE VIDEO                  DOWNLOAD THE FACTSHEET
 
 
 Chromosome_Icon_LandingPage.png
 
WHAT IS TMB?
 
Tumor Mutational Burden (TMB) is a validated, clinical marker
 associated with response to immunotherapy
 
VIEW INFOGRAPHIC
 

 

Clipboard_Icon.png

A SINGLE COMPREHENSIVE
SOLUTION

We offer a single report for oncologists facing today's questions with the latest breakthroughs in testing. Our FoundationOne® and FoundationOne® Heme assays accurately measure TMB to help you better predict your patients' responses to certain immunotherapies

VIEW SAMPLE REPORT

  •     ONE BIOPSY

        that saves time and precious tissue

  •     ONE COMPREHENSIVE ASSAY

        with access to clinically relevant markers

  •     ONE PERSONALIZED REPORT

        with targeted therapies, clinical trials

        and TMB status

  •     EXTENSIVE VALIDATION

        by more than 120 scientific publications

 
 
 
 
ALL OF THIS COMBINED WITH A FULL SUITE OF PATIENT-CENTRIC
SERVICES TO FIND THE RIGHT SOLUTION FOR EACH PERSON
 
Acces_Logo.png